Kits Eyecare Ltd.
TSX:KITS.TOSpecialty Retail
-$0.18 today
- Market cap
- $650.54M
- Beta
- 0.20
- P/E (TTM)
- 126.0
- EPS (TTM)
- $0.10
Volume 0.08M
Average 0.14M
KITS.TO Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Kits Eyecare Ltd.TSX: KITS.TO
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of CA$1.98M rose 23.2% year over year, ahead of the -25.2% change in trailing-twelve-month net income. Sequentially, it rose 648.1% from the prior quarter.
Context
- Net income amounted to 1.5% of revenue in FY2025, down 0.4 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of CA$5.13M (+65.1%) for the fiscal year ending Dec 2026, a step up from the -0.2% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- CA$1.98M+648.1% QoQ
- Last fiscal yearDec 2025
- CA$3.11M-0.2% YoY
- LTMMar 2026
- CA$3.48M-25.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +23.2% | +267.8% | +244.6 pp |
| 1 year | -0.2% | +65.1% | +65.3 pp |
| 3-year CAGR | — | +63.3% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
CAD · from the cash flow
- Latest · FY2025
- 3.11M CAD
- Year-over-year change
- -0.2%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.11M | -0.2% |
| FY2024 | 2024-12-31 | 3.12M | +240.7% |
| FY2023 | 2023-12-31 | (2.22M) | +51.3% |
| FY2022 | 2022-12-31 | (4.55M) | +68.9% |
| FY2021 | 2021-12-31 | (14.62M) | — |
Net Income vs competitors
How KITS.TO compares with its peers on the latest reported figures
- KITS.TO's LTM Mar 2026 net income of CA$3.48M is the 9th largest of the 10 companies compared; the peer median is CA$29.49M.
- Its year-over-year change of -25.2% is the 9th highest of 10, against a peer median of -0.1%.
- Net income amounts to 1.6% of revenue for KITS.TO, versus a peer median of 7.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$62.89M | +47.6% | +45.5% | 28.2% | |
| LTM Apr 2026 | CA$48.11M | +69.9% | -14.7% | 7.9% | |
| LTM Mar 2026 | CA$30.98M | -0.1% | +4.4% | 76.6% | |
| LTM Mar 2026 | CA$30.77M | +145.6% | -38.2% | 0.6% | |
| LTM Mar 2026 | CA$29.49M | -10.7% | +59.2% | 37.2% | |
| LTM Mar 2026 | CA$26.42M | -33.9% | +21.6% | 4.5% | |
| LTM Mar 2026 | CA$24.25M | -8.8% | +8.6% | 4.0% | |
| LTM Mar 2026 | CA$19.3M | -4.9% | +18.4% | 22.9% | |
| LTM Mar 2026 | CA$3.48M | -25.2% | — | 1.6% | |
| LTM Apr 2026 | CA$2.52M | +107.8% | -11.3% | 0.9% | |
| Peer median (excluding KITS.TO) | CA$29.49M | -0.1% | +8.6% | 7.9% | |
Competitors are the stored peer set for KITS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.62M) | (4.55M) | (2.22M) | 3.12M | 3.11M |
| Depreciation & Amortization | 2.67M | 3.52M | 3.19M | 2.66M | 2.38M |
| Deferred Income Tax | (4.23M) | (1.32M) | (676K) | 1.33M | 1.94M |
| Stock-Based Compensation | 1.52M | 1.32M | 513K | 1.01M | 1.09M |
| Change in Working Capital | (6.77M) | 4.07M | 343K | 3.84M | 517K |
| Accounts Receivables | 669K | (457K) | (897K) | (703K) | 142K |
| Inventory | (7.68M) | (2.93M) | 1.01M | (7.08M) | (1.18M) |
| Accounts Payables | (41K) | 6.49M | (703K) | 9.28M | 1.24M |
| Other Working Capital | 278K | 961K | 938K | 2.35M | 313K |
| Other Non-Cash Items | 1.97M | 1.64M | 1.25M | 1.08M | 2.43M |
| Operating Cash Flow | (19.46M) | 4.68M | 2.41M | 13.04M | 11.46M |
| Capital Expenditures | (3.63M) | (258K) | (563K) | (3.15M) | (136K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | (4.99M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (3.63M) | (258K) | (563K) | (3.15M) | (5.13M) |
| Debt Repayment | (9.88M) | (5.13M) | (5.14M) | (4.88M) | 3.02M |
| Common Stock Issued | 55M | 0 | 65K | 0 | 1.84M |
| Common Stock Repurchased | 0 | 0 | 0 | (213K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.64M) | 0 | 65K | 71K | (1.39M) |
| Financing Cash Flow | 41.48M | (5.13M) | (5.07M) | (5.02M) | 3.47M |
| Effect of Forex Changes | (187K) | (1.01M) | 480K | (1.63M) | 736K |
| Net Change in Cash | 18.2M | (1.72M) | (2.75M) | 3.23M | 10.54M |
| Free Cash Flow | (23.09M) | 4.42M | 1.84M | 9.88M | 11.33M |
Kits Eyecare Ltd.
TSX:KITS.TO
Intrinsic Alpha fair value
Locked
Current Price
$19.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.